Filter by: patients
What is Rife Frequency Generator?

This is a generic name for an electronic device that is claimed to kill various pathogens. Such devices are based on the theories of Royal Rife. You can read about him at Wikipedia and find links to futher discussion of his controversial claims. http://en.wikipedia.org/wiki/Royal_Rife Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Increase effect of another treatment 1 0
Other 1 0
ALS (Amyotrophic Lateral Sclerosis) 1 1 Efficacy_none
Dry Eye Syndrome 1 1 Efficacy_slight
Celiac Disease 1 1 Efficacy_cant_tell
Ophthalmic Rosacea 1 1 Efficacy_major

See all 2 patients currently using Rife Frequency Generator

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
2

Reported Schedules

  as needed 2 hr weekly
  1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Using (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 50%
Course of treatment ended 1   Course of treatment ended: 50%

See all 2 patients who’ve stopped using Rife Frequency Generator

How Long Current Patients Have Been Using Rife Frequency Generator

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

How Long Patients Used Before Stopping

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Rife Frequency Generator

Always
1 50%
Usually
1 50%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Rife Frequency Generator

Very
0 0%
Somewhat
0 0%
A little
1 50%
Not at all
1 50%

Cost

Paid out of pocket

Cost of Rife Frequency Generator

$200+
1 100%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on February 12, 2012.